Onward Medical N.V./€ONWD
05:30
03:10
00:45
22:25
20:00
1D1W1MYTD1Y5YMAX
About Onward Medical N.V.
ONWARD Medical N.V. is a medical technology company specializing in spinal cord stimulation therapies aimed at restoring movement, function, and independence for individuals with spinal cord injuries (SCI) and other movement disabilities. Founded in 2014 by researchers at the Swiss Federal Institute of Technology (EPFL), the company is headquartered in Eindhoven, the Netherlands, with additional offices in Lausanne, Switzerland, and Boston, Massachusetts. Its product portfolio includes the ARC-EX System, a non-invasive device designed to enhance upper limb function, and the investigational ARC-IM System, an implantable solution targeting blood pressure stability and other SCI-related symptoms. In 2024, ONWARD Medical secured exclusive rights to develop and commercialize the WIMAGINE Brain-Computer Interface (BCI), positioning the company to integrate thought-driven movement capabilities into its therapies. The company has also received multiple Breakthrough Device Designations from the U.S. Food and Drug Administration (FDA) for its innovative approaches to SCI treatment.
Ticker
€ONWD
Sector
Primary listing
BSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
103
ISIN
NL0015000HT4
Website
ONWD Metrics
BasicAdvanced
€202M
-
-€0.80
0.85
-
Price and volume
Market cap
€202M
Beta
0.85
52-week high
€7.24
52-week low
€3.50
Average daily volume
78K
Financial strength
Current ratio
6.847
Quick ratio
6.574
Long term debt to equity
30.154
Total debt to equity
31.396
Interest coverage (TTM)
-38.78%
Profitability
EBITDA (TTM)
-34.506
Gross margin (TTM)
-699.60%
Net profit margin (TTM)
-2,054.34%
Operating margin (TTM)
-2,006.90%
Effective tax rate (TTM)
0.11%
Revenue per employee (TTM)
€20,000
Management effectiveness
Return on assets (TTM)
-36.37%
Return on equity (TTM)
-108.28%
Valuation
Price to revenue (TTM)
117.747
Price to book
4.21
Price to tangible book (TTM)
5.38
Price to free cash flow (TTM)
-6.416
Free cash flow yield (TTM)
-15.59%
Free cash flow per share (TTM)
-71.51%
Growth
Revenue change (TTM)
219.55%
Earnings per share change (TTM)
-33.29%
3-year revenue growth (CAGR)
7.52%
3-year earnings per share growth (CAGR)
-39.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Onward Medical N.V. stock?
Onward Medical N.V. (ONWD) has a market cap of €202M as of July 11, 2025.
What is the P/E ratio for Onward Medical N.V. stock?
The price to earnings (P/E) ratio for Onward Medical N.V. (ONWD) stock is 0 as of July 11, 2025.
Does Onward Medical N.V. stock pay dividends?
No, Onward Medical N.V. (ONWD) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Onward Medical N.V. dividend payment date?
Onward Medical N.V. (ONWD) stock does not pay dividends to its shareholders.
What is the beta indicator for Onward Medical N.V.?
Onward Medical N.V. (ONWD) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.